A number of factors such as increasing incidence of lifestyle-associated and chronic illnesses, improving healthcare infrastructure, and rising healthcare spending are expected to propel the embolotherapy market at a CAGR of 7.7% during 2020–2030. According to P&S Intelligence,...
